Skip to main content

Table 1 Percentage of fibroblasts and contaminating cells in primary cultures of RA and OA synovial fibroblast cells at various passages

From: Suppressive effect of secretory phospholipase A2inhibitory peptide on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice

Passage

Cell type

% positive cells (Mean ± SEM)*

  

RA SF

OA SF

First

Fibroblast (Prolyl-4-hydroxylase +)1

75 ± 8.0

68 ± 5.0

 

Monocyte/macrophage (CD14+)2

15 ± 2.0

21 ± 3.5

 

T-cells (CD3+)3

0.8 ± 0.2

1.2 ± 0.3

 

B-cells (CD20+)4

0.9 ± 0.3

0.8 ± 0.2

Third

Fibroblast (Prolyl-4-hydroxylase +)

99 ± 0.5

98.5 ± 0.6

 

Monocyte/macrophage (CD14+)

0.8 ± 0.2

0.6 ± 0.1

 

T-cells (CD3+)

0.5 ± 0.1

0.8 ± 0.2

 

B-cells (CD20+)

0.6 ± 0.2

0.5 ± 0.1

Fourth

Fibroblast (Prolyl-4-hydroxylase +)

98 ± 0.4

99.2 ± 0.4

 

Monocyte/macrophage (CD14+)

1.0 ± 0.5

0.95 ± 0.3

 

T-cells (CD3+)

0.5 ± 0.2

0.5 ± 0.1

 

B-cells (CD20+)

0.9 ± 0.1

0.8 ± 0.1

  1. * Total number = five rheumatoid arthritis (RA) and five osteoarthritis (OA) patients. Monoclonal antibodies used for flow cytometry: mAb 5B5 1; mAb Tyk4 2; mAb UCHT-1 3; mAb B-Ly1 4. SEM = standard error of the mean; SF = synovial fluid.